Esperion Therapeutics, Inc. (ESPR): Price and Financial Metrics
ESPR Price/Volume Stats
| Current price | $2.41 | 52-week high | $3.40 |
| Prev. close | $2.41 | 52-week low | $1.15 |
| Day low | $2.31 | Volume | 4,286,600 |
| Day high | $2.45 | Avg. volume | 6,167,062 |
| 50-day MA | $2.00 | Dividend yield | N/A |
| 200-day MA | $2.22 | Market Cap | 474.85M |
ESPR Stock Price Chart Interactive Chart >
Esperion Therapeutics, Inc. (ESPR) Company Bio
Esperion Therapeutics is focused on developing and commercializing first-in-class, oral, LDL-cholesterol-lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. The company was founded in 1998 and is based in Ann Arbor, Michigan.
ESPR Price Returns
| 1-mo | 13.15% |
| 3-mo | 36.16% |
| 6-mo | 13.15% |
| 1-year | 99.17% |
| 3-year | -66.15% |
| 5-year | -95.14% |
| YTD | -19.40% |
| 2023 | -52.01% |
| 2022 | 24.60% |
| 2021 | -80.77% |
| 2020 | -56.40% |
| 2019 | 29.63% |
Continue Researching ESPR
Want to do more research on Esperion Therapeutics Inc's stock and its price? Try the links below:Esperion Therapeutics Inc (ESPR) Stock Price | Nasdaq
Esperion Therapeutics Inc (ESPR) Stock Quote, History and News - Yahoo Finance
Esperion Therapeutics Inc (ESPR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...